Lu Hongbo
SEC CIK 1767584 · EDGAR
BoughtSold
Most active insiders at ARWR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Anzalone Christopher Richard | CEO, Dir | — | $24.01M |
| 2 | Hamilton James C | Chief Medical Off | — | $4.63M |
| 3 | O'Brien Patrick | COO | — | $3.12M |
| 4 | PERRY MICHAEL S | Dir | — | $2.00M |
| 5 | Ferrari Mauro | Dir | — | $1.02M |
| 6 | Apel Daniel Joseph | CFO | — | $934.3K |
| 7 | OLUKOTUN ADEOYE Y | Dir | — | $850.5K |
| 8 | Vakiener Victoria | Dir | — | $679.5K |
| 9 | Waddill William D. | Dir | — | $566.0K |
| 10 | Lu Hongbo | Dir | — | $228.3K |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-14 19:05 | 2026-05-12 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Lu Hongbo | Dir | S - Sale | $76.88 | -2,970 | 52.0K | -5% | -$228.3K |
| I | 2026-04-02 17:02 | 2026-03-31 | ZBIO | Zenas BioPharma, Inc. | Lu Hongbo | Dir | P - Purchase | $18.63 | +3,768 | 426.7K | +0.9% | +$70.2K |
| I | 2026-03-31 | 2026-03-31 | ZBIO | Zenas BioPharma, Inc. | Lu Hongbo | Dir | P - Purchase | $20.00 | +75.0K | 423.0K | +22% | +$1.50M |
| I | 2026-02-13 | 2026-02-11 | ZBIO | Zenas BioPharma, Inc. | Lu Hongbo | Dir | P - Purchase | $22.50 | +26.0K | 348.0K | +8% | +$584.7K |
| 2025-12-18 | 2025-12-16 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Lu Hongbo | Dir | A - Grant | $0.00 | +7,819 | 55.0K | +17% | $0 | |
| MI | 2025-10-09 | 2024-09-13+ | ZBIO | Zenas BioPharma, Inc. | Lu Hongbo | Dir | P - Purchase | $18.63 | +322.0K | 322.0K | New | +$6.00M |
| 2024-12-20 | 2024-12-18 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Lu Hongbo | Dir | A - Grant | $22.99 | +16.7K | 47.2K | +55% | +$384.7K | |
| I | 2024-09-17 | 2024-09-13 | ZBIO | Zenas BioPharma, Inc. | Lu Hongbo | Dir | P - Purchase | $17.00 | +58.8K | 58.8K | New | +$1000.0K |
| M | 2024-03-20 | 2024-03-18+ | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Lu Hongbo | Dir | P - Purchase | $27.66 | +3,000 | 32.7K | +10% | +$83.0K |
Purchase Sale Sale after option exercise All abbreviations